Cargando…
Investigation of the Protective Effect for GcMAF by a Glycosidase Inhibitor and the Glycan Structure of Gc Protein
O-linked α-N-acetylgalactosamine (α-GalNAc) in the Gc protein is essential for macrophage activation; thus, the GalNAc-attached form of Gc protein is called Gc macrophage activating factor (GcMAF). O-linked glycans in Gc proteins from human plasma mainly consist of trisaccharides. GcMAF is produced...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963009/ https://www.ncbi.nlm.nih.gov/pubmed/36838558 http://dx.doi.org/10.3390/molecules28041570 |
_version_ | 1784896144717905920 |
---|---|
author | Kanie, Yoshimi Maegawa, Yuya Wei, Yi Kanie, Osamu |
author_facet | Kanie, Yoshimi Maegawa, Yuya Wei, Yi Kanie, Osamu |
author_sort | Kanie, Yoshimi |
collection | PubMed |
description | O-linked α-N-acetylgalactosamine (α-GalNAc) in the Gc protein is essential for macrophage activation; thus, the GalNAc-attached form of Gc protein is called Gc macrophage activating factor (GcMAF). O-linked glycans in Gc proteins from human plasma mainly consist of trisaccharides. GcMAF is produced when glycans on the Gc protein are hydrolyzed by α-Sia-ase and β-Gal-ase, leaving an α-GalNAc. Upon hydrolysis of α-GalNAc present on GcMAF, the protein loses the macrophage-activating effect. In contrast, our synthesized pyrrolidine-type iminocyclitol possessed strong in vitro α-GalNAc-ase inhibitory activity. In this study, we examined the protective effects of iminocyclitol against GcMAF via inhibition of α-GalNAc-ase activity. Detailed mass spectrometric analyses revealed the protective effect of the inhibitor on GcMAF. Furthermore, structural information regarding the glycosylation site and glycan structure was obtained using tandem mass spectrometric (MS/MS) analysis of the glycosylated peptides after tryptic digestion. |
format | Online Article Text |
id | pubmed-9963009 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99630092023-02-26 Investigation of the Protective Effect for GcMAF by a Glycosidase Inhibitor and the Glycan Structure of Gc Protein Kanie, Yoshimi Maegawa, Yuya Wei, Yi Kanie, Osamu Molecules Article O-linked α-N-acetylgalactosamine (α-GalNAc) in the Gc protein is essential for macrophage activation; thus, the GalNAc-attached form of Gc protein is called Gc macrophage activating factor (GcMAF). O-linked glycans in Gc proteins from human plasma mainly consist of trisaccharides. GcMAF is produced when glycans on the Gc protein are hydrolyzed by α-Sia-ase and β-Gal-ase, leaving an α-GalNAc. Upon hydrolysis of α-GalNAc present on GcMAF, the protein loses the macrophage-activating effect. In contrast, our synthesized pyrrolidine-type iminocyclitol possessed strong in vitro α-GalNAc-ase inhibitory activity. In this study, we examined the protective effects of iminocyclitol against GcMAF via inhibition of α-GalNAc-ase activity. Detailed mass spectrometric analyses revealed the protective effect of the inhibitor on GcMAF. Furthermore, structural information regarding the glycosylation site and glycan structure was obtained using tandem mass spectrometric (MS/MS) analysis of the glycosylated peptides after tryptic digestion. MDPI 2023-02-06 /pmc/articles/PMC9963009/ /pubmed/36838558 http://dx.doi.org/10.3390/molecules28041570 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kanie, Yoshimi Maegawa, Yuya Wei, Yi Kanie, Osamu Investigation of the Protective Effect for GcMAF by a Glycosidase Inhibitor and the Glycan Structure of Gc Protein |
title | Investigation of the Protective Effect for GcMAF by a Glycosidase Inhibitor and the Glycan Structure of Gc Protein |
title_full | Investigation of the Protective Effect for GcMAF by a Glycosidase Inhibitor and the Glycan Structure of Gc Protein |
title_fullStr | Investigation of the Protective Effect for GcMAF by a Glycosidase Inhibitor and the Glycan Structure of Gc Protein |
title_full_unstemmed | Investigation of the Protective Effect for GcMAF by a Glycosidase Inhibitor and the Glycan Structure of Gc Protein |
title_short | Investigation of the Protective Effect for GcMAF by a Glycosidase Inhibitor and the Glycan Structure of Gc Protein |
title_sort | investigation of the protective effect for gcmaf by a glycosidase inhibitor and the glycan structure of gc protein |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963009/ https://www.ncbi.nlm.nih.gov/pubmed/36838558 http://dx.doi.org/10.3390/molecules28041570 |
work_keys_str_mv | AT kanieyoshimi investigationoftheprotectiveeffectforgcmafbyaglycosidaseinhibitorandtheglycanstructureofgcprotein AT maegawayuya investigationoftheprotectiveeffectforgcmafbyaglycosidaseinhibitorandtheglycanstructureofgcprotein AT weiyi investigationoftheprotectiveeffectforgcmafbyaglycosidaseinhibitorandtheglycanstructureofgcprotein AT kanieosamu investigationoftheprotectiveeffectforgcmafbyaglycosidaseinhibitorandtheglycanstructureofgcprotein |